Peptide Analysis: The Four Core Questions for Lab Testing

Before you send a peptide to a lab, think about what you really need to know. Four questions matter most: Is it the peptide it claims to be (identity)? How high is the share of the target peptide compared to impurities (purity)? How much active peptide is actually there (content)? And are there any harmful contaminants (safety)?

Each question needs a specific analytical method. Mass spectrometry (MS) is usually used to determine identity, often backed up by peptide mapping. Purity is routinely checked with high-performance liquid chromatography (HPLC). Labs determine content via HPLC assays, quantitative NMR spectroscopy (qNMR), or amino acid analysis. Safety tests look for endotoxins, residual solvents, and heavy metals.

The Peptide Testing Process: From Identity to Safety

The examination follows a logical order: First, identity is established via mass spectrometry, then purity is tested using HPLC. Next, content is determined via an assay, and finally, safety is checked through endotoxin and sterility tests. This order is not a formal requirement for private individuals, but it follows from the purpose of each method.

Why does this sequence make sense? Without confirming identity, purity or safety values are hard to interpret. Only once you know it is the correct peptide do further tests become meaningful. For pharmaceuticals, the FDA also requires a combination of several methods for primary structure analysis, such as amino acid analysis, Edman degradation, and mass spectrometry.

Costs and Time: The Trade-off in Peptide Testing

Each additional analytical method gives you deeper data, but it also raises costs and processing time. That is because each technique needs its own equipment, reagents, and specific sample preparation and evaluation. The sources do not provide specific figures for this trade-off.

However, regulatory requirements show that a complete characterization demands complementary methods. For example, the EMA requires a broad panel of methods for comparability studies. A multi-laboratory study also showed variations between different quantification methods, such as HPLC assay, qNMR, and amino acid analysis, for the same peptide, underscoring the importance of method selection.

Basic Panel or Full Analysis: When Are Extensions Useful?

A basic panel to determine identity and purity often serves as an entry point into peptide testing. If you only want to know whether the peptide is correct and pure, this may be enough. However, extending the analysis to include content (assay) is useful to know the exact amount of the active peptide, since HPLC purity does not tell you about contained water, salts, or counterions.

Safety tests for endotoxins, residual solvents, or heavy metals are relevant when you worry about possible contamination. The sources emphasize that purity is not the same as content: A sample can have high HPLC purity and still contain significant amounts of non-peptide material, which is why an assay is necessary for a complete picture.

Prices for Peptide Analyses: A Rough Guide

Reliable price information for commercial peptide tests is scarce in the sources. One lab provider's website lists 195 dollars per sample for identity and purity via HPLC, though this figure serves only as an example due to its source.

A documented reference point: At the widely used testing lab Janoshik Analytical, prices range from 145 to 500 US dollars per test according to their own website (as of July 2026). You can find more labs with public pricing and sources in the lab directory.

Representativeness: Why the Result Only Applies to the Tested Sample

An analysis result refers exclusively to the specific physical sample that was submitted. In pharmaceutical regulation, batch testing of multiple batches is therefore mandatory. The FDA requires detailed batch analysis reports, and for generic peptides, at least three batches with two different active ingredient batches must be evaluated.

For you, this means: A test result for a single vial does not allow reliable conclusions about other vials from the same order. Additionally, the quality of labs varies significantly. In a HUPO study, only 7 out of 27 labs initially provided correct results. It is therefore advisable to look for accredited labs with transparent methods.

Limitations and Regulatory Standards (USP, FDA)

The standards used, such as USP (United States Pharmacopeia), Ph. Eur., FDA, and EMA, were developed for pharmaceutical products. They cannot be automatically applied to research peptides or samples from the gray market. There are no sources that address the specific context of private individuals testing unregulated peptides.

Furthermore, regulatory thresholds for impurities come from the pharmaceutical world - for example, the reporting requirement from 0.1% or the identification requirement from 0.5%. Whether these limits apply to your specific sample is not documented. The available sources do not allow a definitive statement about their applicability to unregulated peptides.

Define your question Start by deciding what you want to find out: identity, purity, content, or safety. This choice determines which tests you need.
Choose methods Match the methods to your goal: MS checks identity, HPLC checks purity, assay checks content, and LAL checks endotoxins. Each method has its own purpose.
Weigh cost and time Remember that adding more methods raises the cost and takes more time. A basic panel is cheaper, but it tells you less.
Select a laboratory Look at the quality of the lab, because results can differ from one lab to another. Accreditation can be a sign of quality.
Send in a sample Send a sample that represents the batch well. Keep in mind that the result only applies to that sample, not to the whole batch.
Interpret results Read the results with the methods in mind. HPLC purity does not tell you about water or salts - for that, you need the content.

Peptide tests: basic or full panel - what makes sense when